What dose of vasopressin should be administered to a brain‑dead donor with pre‑existing renal failure to achieve a urine‑output target of less than 150 mL per hour?

Vasopressin Dosing for Brain-Dead Donors with Diabetes Insipidus

Titrate parenteral vasopressin to maintain urine output less than 150 mL/hour in brain-dead donors with diabetes insipidus, without using a fixed dose.

Specific Dosing Approach

The most relevant guideline for your specific scenario—managing a brain-dead organ donor with pre-existing renal failure and diabetes insipidus—comes from cardiac transplantation donor management protocols 1. These guidelines recommend titrating vasopressin infusion to achieve the target urine output of <150 mL/hour rather than using a predetermined fixed dose.

Clinical Algorithm:

Step 1: Recognize Diabetes Insipidus

• Urine output >300 mL/hour indicates diabetes insipidus in brain-dead donors 1
• This occurs due to posterior pituitary dysfunction after brain death

Step 2: Initiate Vasopressin

• Start parenteral vasopressin infusion
• Titrate the dose specifically to keep urinary volume <150 mL/hour 1

Step 3: Monitor and Adjust

• The dose is individualized based on urine output response
• No specific starting dose is provided in donor management guidelines—the endpoint is physiologic (urine output control)

Context from Other Clinical Settings

While the donor management guidelines don't specify exact starting doses, other contexts provide reference ranges:

• Septic shock: 0.01-0.07 units/minute 2, 3
• Post-cardiotomy shock: 0.03-0.1 units/minute 2
• FDA-approved dosing: Start at 0.01-0.03 units/minute, titrate by 0.005 units/minute every 10-15 minutes 4
• Organ donor protocols: 0.5-4 units/hour (approximately 0.008-0.067 units/minute) 5
• Historical donor studies: 1-2 units/hour (approximately 285 microunits/kg/minute) 6

Critical Considerations for Your Patient

Renal Failure Impact: The presence of pre-existing renal failure is highly relevant. Recent evidence demonstrates that severe renal dysfunction (eGFR <9.7 mL/min) prevents the clinical manifestation of diabetes insipidus 7. With eGFR 15-60 mL/min, only 54.5% develop DI, and with eGFR <15 mL/min, only 32% manifest DI 7. This means your patient with pre-existing renal failure may require less vasopressin or may not develop polyuria despite posterior pituitary dysfunction.

Hemodynamic Effects:

• Vasopressin causes vasoconstriction and can increase systemic blood pressure 1
• This may necessitate concurrent sodium nitroprusside for afterload reduction 1
• Vasopressin allows reduction of catecholamine doses (dopamine, norepinephrine) 6, 8, 9

Organ Perfusion Concerns:

• Higher vasopressin doses can compromise splanchnic blood flow 10
• Maximum dose of 0.04 units/kg/hour showed reduced mesenteric perfusion in experimental models 10
• Balance hemodynamic stability against organ perfusion for transplantation

Practical Recommendation

For your brain-dead donor with renal failure:

1. If urine output >300 mL/hour develops: Start vasopressin infusion at a low dose (suggest 0.5-1 unit/hour or 0.01 units/minute)
2. Titrate upward in small increments every 15-30 minutes until urine output <150 mL/hour
3. Monitor closely for hypertension requiring nitroprusside
4. Expect lower vasopressin requirements due to pre-existing renal failure reducing DI manifestation
5. Simultaneously wean catecholamines as blood pressure permits

The emphasis in donor management is on the physiologic endpoint (urine output control) rather than a predetermined dose, recognizing that individual donor responses vary significantly based on residual pituitary function and renal capacity 1, 7.